[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100659764":3},{"organization":4,"outcomesModule":7,"designInfo":27,"detailedDescription":34,"studyPopulation":26,"armGroups":35,"interventions":46,"overallOfficials":51,"centralContacts":55,"locations":26,"responsibleParty":61,"collaborators":26,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":26,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":86,"whyStopped":26,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":26},{"fullName":5,"class":6},"University Hospital, Clermont-Ferrand","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":26},[9],{"measure":10,"description":11,"timeFrame":12},"Change in pain levels between enrollment and five days later, measured on a numerical scale ranging from 0 to 10.","Zero is equivalent to no pain and 10 indicates the worst possible pain.","From enrollment to five days later.",[14,18,22],{"measure":15,"description":16,"timeFrame":17},"Change in quality of life between enrolment and five days later (expressed as a percentage), measured using the EQ-5D-5L questionnaire","Using the EQ-5D-5L questionnaire","From enrollment to five days later",{"measure":19,"description":20,"timeFrame":21},"Waiting time for an appointment with a healthcare professional","In days","Between enrollment to five days later",{"measure":23,"description":24,"timeFrame":25},"Patient satisfaction, as measured by perceptions of the quality of overall care and satisfaction with the pathway through the care process","5-point Likert scales","Assessed on the 5th day",null,{"allocation":28,"interventionModel":29,"interventionModelDescription":30,"primaryPurpose":31,"observationalModel":26,"timePerspective":26,"maskingInfo":32},"RANDOMIZED","SEQUENTIAL","A regional, multicentre, sequential-phase, cluster-randomised, comparative, interventional trial.","PREVENTION",{"masking":33,"maskingDescription":26,"whoMasked":26},"NONE","Self-medication is the use of a medicinal product by a person on their own initiative, to treat simple, previously experienced symptoms or minor illnesses. It is a widespread practice and is not without risk, as previous studies have shown. The French national health insurance website, Ameli, therefore stresses the importance of asking one's pharmacist for advice and reading the patient information leaflet carefully.\n\nWhen a patient makes a spontaneous request for a medicine, the pharmacist's role is to identify potential dangers (risk of overdose, drug interactions, etc.) and to propose a solution, such as adjusting the dosage, suggesting an alternative medicine, or referring the patient for a consultation. These recommendations, made to ensure patient safety, are known as \"pharmaceutical interventions\".\n\nRecording and following up on pharmaceutical interventions, particularly when the community pharmacist reaches the limit of what they can advise and decides to refer the patient to another healthcare professional, would help ensure continuity of patient care.\n\nThis study will test the benefits of a liaison form and a follow-up telephone interview with the pharmacist for patients who come to the pharmacy seeking pain relief and whom the pharmacist chooses to refer to a healthcare professional, specifically a general practitioner, a midwife or a dentist. The aim is to compare the value of such a practice with usual care in the pharmacy, by assessing patients' pain levels, quality of life and satisfaction.",[36,42],{"label":37,"type":38,"description":39,"interventionNames":40},"Monitoring by a telephone call from the pharmacist three days after the pharmaceutical intervention","EXPERIMENTAL","Three days after carrying out a pharmaceutical intervention prompted by the patient's request for self-medication for pain - during which the patient was advised to consult a healthcare professional and was given a referral form - the community pharmacist conducts a follow-up by telephone to optimise the patient's care and assess the urgency of the situation.",[41],"Other: Care monitoring by the pharmacist's telephone call",{"label":43,"type":44,"description":45,"interventionNames":26},"Standard of care","NO_INTERVENTION","Referral to a healthcare professional following a pharmaceutical intervention after the patient had self-medicated for pain, without any follow-up by the pharmacist.",[47],{"type":6,"name":48,"description":49,"armGroupLabels":50,"otherNames":26},"Care monitoring by the pharmacist's telephone call","The pharmacist completes a referral form for the healthcare professional and gives it to the patient. Three days later, he calls the patient to follow up and optimise the patient's care and assess the urgency of the situation.",[37],[52],{"name":53,"affiliation":5,"role":54},"Chantal Savanovitch","PRINCIPAL_INVESTIGATOR",[56],{"name":57,"role":58,"phone":59,"phoneExt":26,"email":60},"Lise Laclautre","CONTACT","0473754963","promo_interne_drci@chu-clermontferrand.fr",{"type":62,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100659764","impact-of-pharmaceutical-intervention-in-self-medication-focus-on-pain-management-in-pharmacies-100659764",false,"NCT07867301","Impact of Pharmaceutical Intervention in Self-Medication: Focus on Pain Management in Pharmacies","AUTOMED'IP-DOL","Inclusion Criteria:\n\n* An adult patient visiting the pharmacy, who has been issued with a referral following a spontaneous request for a medicine to treat pain and has been referred for a consultation with a healthcare professional.\n* Enrolled in a social security scheme,\n* Able to read and understand the information leaflet, and to give informed consent to take part.\n\nPregnant and breastfeeding women will be included in the study in accordance with the available literature\n\nExclusion Criteria:\n\n* Patients who cannot be monitored for psychological reasons,\n* Patients under guardianship or trusteeship, deprived of their liberty or subject to judicial protection,\n* Patients who refuse to take part in the study,\n* Patients taking part in another interventional research study involving an exclusion period that is still ongoing at the time of inclusion,\n* A person acting on behalf of a third party,\n* A patient for whom a pharmaceutical intervention is initiated following:\n\n  * a request accompanied by a prescription,\n  * a request for advice,\n  * a request for a veterinary medicine,\n  * a request for a medicine from abroad,\n  * a request for a medicine that has been withdrawn from the French market,\n  * a request concerning a health product other than a medicine.","ALL","18 Years",{"count":73,"type":74},376,"ESTIMATED","INTERVENTIONAL",[77],"NA","Self-medication is an increasingly common practice that carries risks. When a patient requests self-medication, the community pharmacist intervenes in the identification, prevention and resolution of medication-related problems. Previous work led to the validation of a reporting grid for pharmaceutical interventions and to the creation of a database of several thousand pharmaceutical interventions in self-medication. Thirty per cent of these are associated with a complaint of pain.\n\nRecording these interventions and following up on their outcomes, particularly when the community pharmacist is at the limit of their advisory role and referral to another healthcare professional is required, would help promote coordinated practice among primary care professionals and could even inform public health policy. The AUTOMED'IP-DOL study will test the introduction of a liaison form and a brief pharmaceutical follow-up interview for pharmaceutical interventions arising from a spontaneous request in a context of pain and leading to the patient being referred to a consultation with a healthcare professional. The aim is to compare the value of such a practice with usual care in the pharmacy, by assessing patients' pain levels, quality of life and satisfaction.",[80,81],"Self-medication for Pain","Limits on Advice From Community Pharmacists and Referral to a Primary Care Practitioner",[83,84,85],"self-medication","pain","community pharmacists' intervention","NOT_YET_RECRUITING","2026-10-05",{"date":89,"type":90},"2026-10-09","ACTUAL",{"date":92,"type":74},"2026-11-28",{"date":94,"type":74},"2028-01",{"name":5,"class":6}]